Different Schemes of Magnesium Sulfate for Preeclampsia
Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Eclampsia is an obstetric emergency capable of prophylaxis. To prevent and control seizures,
there is no doubt that the magnesium sulfate (MgSO4) is the ideal drug. However, there are
still questions regarding its use and dose. The scheme and the optimal time of administration
remain to be elucidated. The objective of this trial is to compare the effectiveness and
safety of intravenous magnesium sulfate in the maintenance phase 1g / h versus 2 g / h to
prevent eclampsia in pregnant and postpartum women with severe preeclampsia (pure or
superimposed).
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Materno Infantil Prof. Fernando Figueira